Item 16. Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.



	LENNAR CORPORATION

	/S/ RICHARD BECKWITT
	Richard Beckwitt
	Chief Executive Officer and Director
	Date:	January 28, 2019

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:



Principal Executive Officer:

Richard Beckwitt	/S/ RICHARD BECKWITT
Chief Executive Officer and Director	Date:	January 28, 2019

Principal Financial Officer:

Diane Bessette	/S/ DIANE BESSETTE
Vice President, Chief Financial Officer and Treasurer	Date:	January 28, 2019

Principal Accounting Officer:

David Collins	/S/ DAVID COLLINS
Controller	Date:	January 28, 2019

Directors:

Irving Bolotin	/S/ IRVING BOLOTIN
	Date:	January 28, 2019

Steven L. Gerard	/S/ STEVEN L. GERARD
	Date:	January 28, 2019

Theron I. ("Tig") Gilliam, Jr.	/S/ THERON I. ("TIG") GILLIAM, JR.
	Date:	January 28, 2019

Sherrill W. Hudson	/S/ SHERRILL W. HUDSON
	Date:	January 28, 2019

Jonathan M. Jaffe	/S/ JONATHAN M. JAFFE
	Date:	January 28, 2019

Sidney Lapidus	/S/ SIDNEY LAPIDUS
	Date:	January 28, 2019

Teri McClure	/S/ TERI MCCLURE
	Date:	January 28, 2019

Stuart Miller	/S/ STUART MILLER
	Date:	January 28, 2019

Armando Olivera	/S/ ARMANDO OLIVERA
	Date:	January 28, 2019

Jeffrey Sonnenfeld	/S/ JEFFREY SONNENFELD
	Date:	January 28, 2019

Scott Stowell	/S/ SCOTT STOWELL
	Date:	January 28, 2019

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the shareholders and the Board of Directors of Lennar Corporation

Opinion on the Financial Statement Schedule

We have audited the consolidated financial statements of Lennar Corporation and subsidiaries (the "Company") as of November 30, 2018 and 2017, and for each of the three years in the period ended November 30, 2018, and the Company's internal control over financial reporting as of November 30, 2018, and have issued our reports thereon dated January 28, 2019; such reports are included elsewhere in this Form 10-K. Our audits also included the financial statement schedule of the Company listed in the Index at Item 15. This financial statement schedule is the responsibility of the Company's management. Our responsibility is to express an opinion on the Company’s financial statement schedule based on our audits. In our opinion, such financial statement schedule, when considered in relation to the financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.



/s/ Deloitte & Touche LLP



Miami, Florida
January 28, 2019

LENNAR CORPORATION AND SUBSIDIARIES

Schedule II—Valuation and Qualifying Accounts

Years Ended November 30, 2018**,** 2017 and 2016



			Additions
(In thousands)	Beginning balance		Charged to costs and expenses	Charged (credited) to other accounts		Deductions		Ending balance
Year ended November 30, 2018
Allowances deducted from assets to which they apply:
Allowances for doubtful accounts and notes and other receivables	$	2,849	246	(156	)	(146	)	2,793
Allowance for loan losses and loans receivable	$	3,192	2,177	3,890		(3,105	)	6,154
Allowance against net deferred tax assets	$	6,423	796	—		—		7,219
Year ended November 30, 2017
Allowances deducted from assets to which they apply:
Allowances for doubtful accounts and notes and other receivables	$	328	260	2,463		(202	)	2,849
Allowance for loan losses and loans receivable	$	33,575	32,850	(1	)	(63,232	)	3,192
Allowance against net deferred tax assets	$	5,773	650	—		—		6,423
Year ended November 30, 2016
Allowances deducted from assets to which they apply:
Allowances for doubtful accounts and notes and other receivables	$	768	125	(88	)	(477	)	328
Allowance for loan losses and loans receivable	$	39,486	18,818	—		(24,729	)	33,575
Allowance against net deferred tax assets	$	5,945	—	—		(172	)	5,773

Previous: Item 15. Exhibits, Financial Statement Schedules.